Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Hemerion Therapeutics

France 37 Rue Denis Papin, 59650 Villeneuve d'Ascq, France

About the sponsor

Hemerion Therapeutics focuses on clinical research in high-grade glioma, with particular interest in glioblastoma and grade IV glioblastoma.

  • Glioblastoma
  • High-grade glioma
  • Malignant brain tumours

The sponsor’s research activity is centered on therapies intended for patients with aggressive primary central nervous system tumours.

About Specializations

Hemerion Therapeutics runs clinical trials in conditions such as Glioblastoma, Malignant glioma, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Glioblastoma+1

Not recruiting
InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Aminolevulinic Acid Hydrochloride
  • Sponsor:Hemerion Therapeutics

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.